Tech Company Financing Transactions
NeuMoDx Molecular Funding Round
NeuMoDx Molecular closed a $4 million funding round on 3/22/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/22/2018
Transaction Type
Debt
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1250 Eisenhower Pl.
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Overview
NeuMoDx Molecular, Inc. will provide hospital and clinical reference laboratories with a vastly superior solution for in vitro molecular diagnostic (MDx) testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Williams
President
Sundu Brahmasandra
VP - Bus. Development
Daniel Harma
VP - Marketing
Jason Ong
VP - Regulatory Affairs
Nahed Mohsen
Browse more venture capital transactions:
Prev: 3/22/2018: eToro venture capital transaction
Next: 3/22/2018: Sift Science venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs